Residential Cognitive and Interpersonal Therapy for Social Phobia

This study has been completed.
Sponsor:
Information provided by:
Modum Bad
ClinicalTrials.gov Identifier:
NCT00326430
First received: May 15, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
  Purpose

The purpose of this study is twofold: (1) to compare the effectiveness of two promising treatments for social phobia, a new cognitive therapy model (Clark & Wells, 1995; Borge et al., 2001) and interpersonal therapy (Lipsitz, Markowitz, & Cherry, 1997), adapted for inpatient groups; and (2) to study the empirical change processes in these therapies and compare them with the cognitive and interpersonal models of change.


Condition Intervention Phase
Social Phobia
Behavioral: Cognitive Therapy, Interpersonal Therapy
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Residential Cognitive Therapy Versus Residential Interpersonal Therapy for Social Phobia: A Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Modum Bad:

Primary Outcome Measures:
  • Social Avoidance
  • Social Anxiety

Secondary Outcome Measures:
  • General Anxiety
  • Depression
  • Interpersonal Problems
  • Personality Disorders

Estimated Enrollment: 80
Study Start Date: October 2001
Estimated Study Completion Date: June 2004
Detailed Description:

Social phobia typically leads to severe impairment in work and other social life, and - without treatment - it can persist for decades. Given its prevalence, severity, and chronicity, effective treatment methods are strongly needed. However, traditional psychological and pharmacological treatments have had statistically significant, but clinically limited effects (Taylor, 1996).

Based on an empirical analysis of the cognitive processes in social phobia, Clark and Wells (1995) have developed a new cognitive model. Cognitive therapy (CT) derived from this model has been found to be superior to a combination of fluoxetine and self-exposure (Clark et al., 2003).

Social phobic symptoms may be viewed as a result of more general interpersonal difficulties and interpersonal psychotherapy (IPT) can be a reasonable alternative for social phobia (Lipsitz & Markowitz, 1996). A clinical case series indicates that social phobic patients improve during interpersonal psychotherapy for social phobia (IPT-SP; Lipsitz et al., 1999.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV criteria for social phobia
  • the patient consider social phobia as the main current problem
  • willingness to suspend use of psychotropic medication, alcohol and other substances
  • acceptance of random allocation
  • ability to speak Norwegian
  • age 18-65 years.

Exclusion Criteria:

  • a history of recurrent major depression currently treated sucessfully with antidepressant medications
  • has immediate need for additional treatment
  • current psychotic disorder or substance abuse
  • organic mental disorder
  • previously treated with similar models
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00326430

Locations
Norway
Modum Bad
Vikersund, Buskerud, Norway, N-3370
Sponsors and Collaborators
Modum Bad
Investigators
Study Chair: Asle Hoffart, Dr Psychol Modum Bad
Principal Investigator: Finn-Magnus Borge, Cand Psychol Modum Bad
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00326430     History of Changes
Other Study ID Numbers: 1
Study First Received: May 15, 2006
Last Updated: May 15, 2006
Health Authority: Norway: Medicine
Norway: The National and Regional Committees for Medical Research Ethics, NEM and REK

Keywords provided by Modum Bad:
Social Phobia
Cognitive Therapy
Interpersonal Therapy
Efficacy
Process-Outcome

Additional relevant MeSH terms:
Phobic Disorders
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 16, 2014